The Radiotherapy Development Branch has as its primary mission the support of extramural research into mechanisms of radiation interaction with biologic systems and materials and application of radiation for therapeutic purposes. The branch oversees grants in a wide range of topics including radiation physics, radiobiology of tumor and normal cells and tissues, development of novel therapeutic tools and development of predictive assays and biomarkers of tumor and normal tissue responses. The grant portfolio is thus wide ranging and is managed by four program directors, each with their own area of expertise.
In addition to grants management RDB: brings together experts from a range of fields to foster improved understanding and therapeutic utility of radiation and other forms of energy, is involved with NIAID and BARDA on issues of radiologic protection, works with other Federal agencies to define knowledge gaps and research opportunities, and develops proposals for funding through the SBIR/STTR program. RDB is also involved in promoting radiobiology education.